- Simulations Plus Positioned to Capitalize on FDA’s Streamlined Nonclinical Safety Guidance with Advanced Mechanistic and Model-Informed Solutions (12/09/2025)
- Simulations Plus and the Institute of Medical Biology of the Polish Academy of Sciences Partnership Announces Results in Validation of ADMET Predictor® Models with Enhanced AI Drug Design (07/30/2025)
- Simulations Plus Invests in Clinical Development Technology Company Nurocor (07/14/2025)
- Simulations Plus Supports New FDA Roadmap for Reducing Animal Testing in Preclinical Safety Studies (04/21/2025)
- Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus® Enhancements (01/22/2025)
- Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024 (01/13/2025)